Business
Currency:USD
2024/Q2
Stock NameRevenueRatio
Dermatology Products Sales14.86M99.72%
Pharmaceutical and Biotechnology Product Development41K0.28%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States84.51M100.00%